about
Defining the potential of neoadjuvant chemotherapy use as a quality indicator for bladder cancer care.Efficacy of robot-assisted radical cystectomy (RARC) in advanced bladder cancer: results from the International Radical Cystectomy Consortium (IRCC)Gleason 6 Prostate Cancer: Translating Biology into Population Health.Complications following primary and revision transsphenoidal surgeries for pituitary tumors.Routine pathology evaluation of hydrocele and spermatocele specimens is associated with significant costs and no identifiable benefit.Complications of primary and revision functional endoscopic sinus surgery for chronic rhinosinusitis.Evaluating the safety of intraoperative instillation of intravesical chemotherapy at the time of nephroureterectomyImpact of Robotic Fellowship Experience on Perioperative Outcomes of Robotic-Assisted Laparoscopic Partial Nephrectomy.11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.Does Routine Pathology Analysis of Adult Circumcision Tissue Identify Penile Cancer?Combination of BCG and interferon intravesical immunotherapy: an update.Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men without comorbidity.Laparoscopic prostatectomy for prostate cancer: continued role in urology.Prostate cancer chemoprevention.Obesity as defined by waist circumference but not body mass index is associated with higher renal mass complexity.Intravesical and alternative bladder-preservation therapies in the management of non-muscle-invasive bladder cancer unresponsive to bacillus Calmette-Guérin.Experience with Sequential Intravesical Gemcitabine and Docetaxel as Salvage Therapy for Non-Muscle Invasive Bladder Cancer.Emerging Impact of Malnutrition on Surgical Patients: Literature Review and Potential Implications for Cystectomy in Bladder Cancer.Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapyBacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.Vaccine immunotherapy for prostate cancer: from mice to men.Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.Malnutrition Diagnosis during Adult Inpatient Hospitalizations: Analysis of a Multi-Institutional Collaborative Database of Academic Medical Centers.Trends in Operating Room Assistance for Major Urologic Surgical Procedures: An Increasing Role for Advanced Practice Providers.Evaluating the Effectiveness, Efficiency and Safety of Telemedicine for Urological Care in the Male Prisoner Population.Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.Reply from authors re: Manfred P. Wirth, Johannes Huber. What really matters is rarely measured: outcome of routine care and patient-reported outcomes. Eur Urol 2013;64:58-9: robot-assisted versus open radical cystectomy: beating a dead horse.Reply: To PMID 25872693.Reply to Michael Froehner's letter to the editor re: Kenneth G. Nepple, Andrew J. Stephenson, Dorina Kallogjeri, et al. Mortality after prostate cancer treatment with radical prostatectomy, external-beam radiation therapy, or brachytherapy in men wiGiant renal angiomyolipoma without fat density on CT scan: case report and review of the literature.Autoimmune retinopathy and optic neuropathy associated with enolase-positive renal oncocytomaEfficacy of transcutaneous electrical nerve stimulation in children with overactive bladder refractory to pharmacotherapyConcordance of preoperative prostate endorectal MRI with subsequent prostatectomy specimen in high-risk prostate cancer patientsFactors affecting response to bacillus Calmette-Guérin plus interferon for urothelial carcinoma in situBenchtop evaluation of pressure barrier insufflator and standard insufflator systemsIgG4 related disease of the ureter (inflammatory pseudotumor)Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder
P50
Q34021124-C9521B3D-7604-4589-B8C3-650E52D8448EQ34337059-B0389841-AE73-45BB-B99C-0509C64A1DFDQ34470640-29DAB1DE-FEC0-4201-AD3E-EFBC992F60CCQ35007896-C49D4865-A926-4114-AEDA-7A816C99158FQ35158016-26F8DE6B-7B03-4E73-BCA3-5C17A36B5EE8Q35170552-ABD66A58-E574-4AC2-BC27-65D267C2654DQ35644091-F43FFAA5-7EC2-42A7-958F-72C06881A855Q36682405-0FEFF388-075A-4EC5-B5E7-63835AA0DA5AQ37209479-DA9419E9-9045-4C8E-AD4C-2BD8FD77E9C9Q37246235-DA1313FD-8314-48A4-BEC1-6D0490945952Q37500031-A04182AE-CD2C-4619-A5AF-CE6EB8E0331DQ37594735-B75F81E4-7CC5-4F54-A300-24A754489F5DQ38060295-153A3694-8E91-4DB6-8F4F-DB834FB07F7BQ38117453-FA2CCE77-722B-4ED1-ABBD-A099B87CF841Q38630065-FB73E7E3-16C1-42B3-A1BF-E2B596E82A71Q38699990-2B515EB0-4746-400E-8612-D0DC4A339A91Q38770375-BE31DD94-CDD6-4AFD-B0F2-15DF6C1DF034Q38912421-D584916B-3BBA-4517-B0DA-A2B0946A85C7Q39262556-7D1E9734-70A1-481B-806B-EB173C407B0CQ40348441-956BA376-BC6F-4EDF-8C99-14034078E944Q42217435-A659ED27-F381-41C9-9BA4-8702C7911F10Q42625988-603B002F-0CE8-48ED-80F9-0B4801C69677Q47392969-BF02B99A-C93E-4858-B7A2-432C73EE37C3Q48507525-ED525B0E-47E6-48AB-80F7-1C7F4AF2A801Q50052090-39E94FA6-A394-40AD-9CBD-8C49A1B43F79Q50505142-707D4F1A-CE0F-4630-9BAD-6D300A7EE1A9Q51241301-0290B016-5915-4314-B032-CC3156B8860DQ53545200-F2C7B442-53EC-43BD-AC28-B3775D0B4E67Q54475688-7A761A15-2365-439C-84BF-320F0312C082Q55669989-28337372-6B8A-4B5E-8AC4-6BADBC4E0DA9Q58754086-C90107F7-FDE6-4052-92C9-F24D2F83E86CQ81403987-8A12DF96-5AFC-4159-BB79-21F5FE827324Q84338527-4A9C40D8-DFC2-44F2-86A2-BCC80B64DD89Q84592315-37CA07EA-5DA9-40F1-A730-170A8FBA1D43Q84623633-C7CD6F4C-4EBF-44AC-8D13-4A537F583040Q87123351-C6A536FC-982B-43F7-BABB-9A660FD58693Q90703106-A58B3AD7-F556-4992-A374-58BB4253D90D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kenneth G Nepple
@ast
Kenneth G Nepple
@en
Kenneth G Nepple
@es
Kenneth G Nepple
@nl
type
label
Kenneth G Nepple
@ast
Kenneth G Nepple
@en
Kenneth G Nepple
@es
Kenneth G Nepple
@nl
prefLabel
Kenneth G Nepple
@ast
Kenneth G Nepple
@en
Kenneth G Nepple
@es
Kenneth G Nepple
@nl
P106
P1153
8982700600
P31
P496
0000-0001-8100-4190